Glycemic control is associated with lower odds of mortality and successful extubation in severe COVID-19
{{output}}
Context: Corticosteroids, specifically dexamethasone, have become the mainstay of treatment for moderate to severe COVID-19. Although the RECOVERY trial did not report adverse effects of corticosteroids, the METCOVID (Methylpredn... ...
